直接口服抗凝剂:关于何时使用和何时避免的快速入门教程
Antoine Bejjani1,2,3, Behnood Bikdeli1,2,4,5
1Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
Thrombosis and haemostasis
|November 18, 2024
概括
直接口服抗凝剂 (DOAC) 提供好处,但应避免在特定的高风险场景. 本次审查澄清了什么时候DOACs是合适的,什么时候需要谨慎或替代治疗来管理血栓栓塞事件.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心血管医学 心血管医学
- 血液学 血液学 血液学
背景情况:
- 在过去的20年里,直接口服抗凝剂 (DOAC) 显著提升了抗血栓治疗.
- 对于心房动和静脉血栓栓塞等疾病,DOAC在很大程度上取代了华法林.
- DOACs提供了优势,包括非劣质的疗效,降低内出血风险,更少的相互作用和更大的便利性.
研究的目的:
- 审查DOAC在血栓塞栓事件治疗和预防中的适当使用.
- 确定特定的临床场景,其中DOAC可能比传统治疗方法效果更差或风险更大.
- 为了指导临床医生在特定疾病和患者子组中使用DOAC.
主要方法:
- 关于DOAC使用的当前文献和临床指南的小型综述.
- 对DOACs与华法林和其他标准治疗方法的比较分析.
- 确定患者群体和有对DOACs的禁忌或不确定性的疾病.
主要成果:
- 对许多患者来说,DOACs是有效和安全的,具有扩展的指示,如降低心血管风险.
- 在特定人群中,DOAC可能具有较低的疗效或安全性,包括那些有机械心脏门或血栓抗脂综合征的人群.
- 关于在某些疾病和患者子组中使用DOAC存在不确定性.
结论:
- 虽然DOAC为许多人提供了一个方便的选择,但必须仔细考虑它们的使用.
- 某些高风险场景需要避免DOACs,转而采用替代的抗凝策略.
- 本综述旨在澄清DOAC的适应性和适应性,以实现最佳的患者管理.
相关概念视频
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
623
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
623
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
471
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
471
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
495
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
495
01:24Disorders of Hemostasis
711
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
711